Inj. pemetrexed nos 10mg
Products billed under this code include Alimta, Pemetrexed.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9305
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Alimta | Eli Lilly and Company | 00002-7623-01 | 50 | $61.50 |
| Alimta | Eli Lilly and Company | 00002-7640-01 | 10 | $12.30 |
| Pemetrexed | Sagent Pharmaceuticals | 25021-0260-10 | 10 | $12.30 |
| Pemetrexed | Sagent Pharmaceuticals | 25021-0261-50 | 50 | $61.50 |
| Pemetrexed | Dr. Reddy's Laboratories Inc. | 43598-0370-74 | 100 | $123.00 |
| Pemetrexed | Dr. Reddy's Laboratories Inc. | 43598-0386-62 | 10 | $12.30 |
| Pemetrexed | Dr. Reddy's Laboratories Inc. | 43598-0387-11 | 50 | $61.50 |
| Pemetrexed | Ingenus Pharmaceuticals LLC | 50742-0341-01 | 50 | $61.50 |
| Pemetrexed | Eugia US LLC | 55150-0381-01 | 10 | $12.30 |
| Pemetrexed | Eugia US LLC | 55150-0382-01 | 50 | $61.50 |
Show all 42 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Pemetrexed | Eugia US LLC | 55150-0383-01 | 100 | $123.00 |
| Pemetrexed | Apotex Corp | 60505-6065-00 | 10 | $12.30 |
| Pemetrexed | Apotex Corp | 60505-6066-00 | 50 | $61.50 |
| Pemetrexed | Apotex Corp | 60505-6067-00 | 100 | $123.00 |
| Pemetrexed | Apotex Corp | 60505-6068-00 | 75 | $92.25 |
| Pemetrexed | FreseniUS Kabi USA, LLC | 63323-0134-10 | 10 | $12.30 |
| Pemetrexed | FreseniUS Kabi USA, LLC | 63323-0450-50 | 50 | $61.50 |
| Pemetrexed | BluePoint Laboratories | 68001-0535-41 | 10 | $12.30 |
| Pemetrexed | BluePoint Laboratories | 68001-0536-41 | 50 | $61.50 |
| Pemetrexed | BluePoint Laboratories | 68001-0538-41 | 10 | $12.30 |
| Pemetrexed | BluePoint Laboratories | 68001-0539-41 | 50 | $61.50 |
| Pemetrexed | BluePoint Laboratories | 68001-0543-41 | 10 | $12.30 |
| Pemetrexed | BluePoint Laboratories | 68001-0544-41 | 50 | $61.50 |
| Pemetrexed | BluePoint Laboratories | 68001-0545-41 | 75 | $92.25 |
| Pemetrexed | BluePoint Laboratories | 68001-0546-41 | 100 | $123.00 |
| Pemetrexed | Somerset Pharma, LLC | 70069-0834-01 | 10 | $12.30 |
| Pemetrexed | Somerset Pharma, LLC | 70069-0835-01 | 50 | $61.50 |
| Pemetrexed | Zydus Pharmaceuticals (USA) Inc. | 70710-1654-01 | 10 | $12.30 |
| Pemetrexed | Zydus Pharmaceuticals (USA) Inc. | 70710-1655-01 | 50 | $61.50 |
| Pemetrexed | Zydus Pharmaceuticals (USA) Inc. | 70710-1674-01 | 100 | $123.00 |
| Pemetrexed | Athenex Pharmaceutical Division, LLC | 70860-0202-10 | 10 | $12.30 |
| Pemetrexed | Athenex Pharmaceutical Division, LLC | 70860-0203-50 | 50 | $61.50 |
| Pemetrexed | Meitheal Pharmaceuticals Inc. | 71288-0147-50 | 75 | $92.25 |
| Pemetrexed | Meitheal Pharmaceuticals Inc. | 71288-0148-51 | 100 | $123.00 |
| Pemetrexed | Meitheal Pharmaceuticals Inc. | 71288-0166-10 | 10 | $12.30 |
| Pemetrexed | Meitheal Pharmaceuticals Inc. | 71288-0166-91 | 10 | $12.30 |
| Pemetrexed | Meitheal Pharmaceuticals Inc. | 71288-0166-92 | 10 | $12.30 |
| Pemetrexed | Meitheal Pharmaceuticals Inc. | 71288-0167-50 | 50 | $61.50 |
| Pemetrexed | Meitheal Pharmaceuticals Inc. | 71288-0167-95 | 50 | $61.50 |
| Pemetrexed | Meitheal Pharmaceuticals Inc. | 71288-0167-96 | 50 | $61.50 |
| Pemetrexed | Northstar RxLLC | 72603-0325-01 | 10 | $12.30 |
| Pemetrexed | Northstar RxLLC | 72603-0425-01 | 50 | $61.50 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.23 | −$5.722 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted September 17, 2026 |
| 3Q26 | $6.952 | +$2.914 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted September 15, 2026 |
| 2Q26 | $4.038 | +$0.444 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted September 15, 2026 |
| 1Q26 | $3.594 | −$0.761 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted September 15, 2026 |
| 4Q25 | $4.355 | +$0.621 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted September 8, 2026 |
| 3Q25 | $3.734 | −$0.037 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted March 10, 2026 |
| 2Q25 | $3.771 | −$1.501 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted March 10, 2026 |
| 1Q25 | $5.272 | +$1.088 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted December 19, 2025 |
| 4Q24 | $4.184 | −$1.431 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted June 11, 2025 |
| 3Q24 | $5.615 | +$1.645 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted June 11, 2025 |
| 2Q24 | $3.97 | −$0.401 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted March 11, 2025 |
| 1Q24 | $4.371 | +$1.148 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted December 19, 2024 |
| 4Q23 | $3.223 | −$4.71 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted October 10, 2024 |
| 3Q23 | $7.933 | −$9.208 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted June 5, 2024 |
| 2Q23 | $17.141 | −$10.54 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted February 23, 2024 |
| 1Q23 | $27.681 | −$20.066 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted December 6, 2023 |
| 4Q22 | $47.747 | −$30.646 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted June 22, 2023 |
| 3Q22 | $78.393 | +$2.009 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted June 9, 2023 |
| 2Q22 | $76.384 | +$0.347 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted December 14, 2022 |
| 1Q22 | $76.037 | +$1.108 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted June 8, 2022 |
| 4Q21 | $74.929 | +$0.732 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted June 2, 2022 |
| 3Q21 | $74.197 | +$1.279 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted June 2, 2022 |
| 2Q21 | $72.918 | −$0.268 | 10 MG | Inj. pemetrexed nos 10mg | v1, posted March 1, 2022 |
| 1Q21 | $73.186 | – | 10 MG | Inj. pemetrexed nos 10mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021